Skip to main content
Premium Trial:

Request an Annual Quote

A Matter of Purpose

The controversy over the University of California, Berkeley's genetic testing project is due to the difference between science and science education, writes Marie-Claire Shanahan, a science education professor, in at guest post at Blog Around the Clock. "They have, in particular, different objectives and different artefacts, rules and actions that guide and shape them," she says. It is there, Shanahan adds, that the Berkeley project gets "fuzzy." How Berkeley describes the project makes it sound educational, yet the tools and some of the language are those of science. "The overall effect is one of a mixed metaphor," she says, and that matters "because the ethical considerations are different."

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.